Skip to main content

Burger Denis R's Form 4/A amendment

Amended

Aptose Biosciences Inc. (APTO) · filed Dec 28, 2021

Accession no.
0001567619-21-022571
Filed
Dec 28, 2021
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 21, 2021

This filing lists no transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $14.5K.

This amendment restates part of 0001567619-21-022365 (filed Dec 21, 2021). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Burger Denis RCIK 0001239414Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001567619-21-022365 (filed Dec 21, 2021).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001567619-21-022365
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 20, 2021Common SharesPPurchaseAcquired+10,000$1.45+$14,50031,671Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On December 21, 2021, the reporting person filed a Form 4 reporting a purchase that occurred on December 20, 2021. The trade was subsequently cancelled by the broker, without any action on the part of the reporting person, resulting in the reporting person's direct ownership of 21,671 common shares of the Issuer.

Read the full filing on SEC EDGAR (opens in a new tab)